Actively Recruiting
The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients
Led by SamA Pharmaceutical Co., Ltd · Updated on 2025-09-23
296
Participants Needed
1
Research Sites
198 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Clinical Study to Evaluate the Efficacy and Safety of Atock Dry Syrup with Acute bronchial Patients
CONDITIONS
Official Title
The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 6 months to under 12 years old
- Bronchitis Severity Scale excluding sputum (BSSEs) score of 4 or higher
- Wheezing score of 2 or higher
- Symptoms of acute bronchitis present within 48 hours before screening
- Negative hepatitis B surface antigen or hepatitis C antibody test within 6 months before screening
You will not qualify if you...
- Chronic respiratory diseases such as asthma or COPD, or severe respiratory illnesses like pneumonia, cystic fibrosis, influenza, or active tuberculosis
- Current treatment with corticosteroids or antibiotics
- Severe liver or kidney problems
- History of drug abuse
- Positive HIV antibody test
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Soonchunhyang University Seoul Hospital
Seoul, South Korea
Actively Recruiting
Research Team
H
Hyeon Jong Yang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here